CV – University of Copenhagen

CV

Personal Data

Name:             Ulrik Gether
Born:              1963.07.27 in Aalborg, Denmark.
Position:          Professor of Neuropharmacology, Head of Department.

Academic degrees

1990:               Doctor of Medicine, University of Copenhagen.
2000:              Dr. Med. Sc., University of Copenhagen. Thesis published as review in Endocrine Rev. (~900 citations according to Web of Science)

Appointments and Training

2017-:             Professor of Neuropharmacology, Head of Department (from September 1st), Department of Neuroscience, University of Copenhagen, Denmark
2015-2017       Professor of Neuropharmacology and Section Head, Department of Neuroscience and Pharmacology, University of Copenhagen, Denmark
2001-2015       Professor of Neuropharmacology, Department of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
1996-2001:      Ole Rømer Associate Research Professor, Division of Cellular and Molecular Physiology, Department of Medical Physiology, University of Copenhagen, Denmark
1993-1996:      Howard Hughes Postdoctoral Fellow, Stanford University Medical School, California, U.S.A. (laboratory of Nobel Laureate, Prof. Brian Kobilka)
1991-1993:      Research Fellow, Lab. of Mol. Endocrinology, Rigshospitalet, Copenhagen, Denmark
1990:              Internship at Department of Medicine, Hvidovre Hospital, Copenhagen, Denmark
1985-1990:      Student in Dr. Thue W. Schwartz's laboratory, Laboratory of Molecular Endocrinology, Rigshospitalet, Copenhagen, Denmark

Selected Positions of Trust and Editorial Work

1996-:            Ad hoc reviewer of manuscripts for Nature, Nature Neuroscience, Nature Structural and Molecular Biology, Nature Chemical Biology, Nature Communication, Proceedings of the National Academy of Sciences U.S.A. J. Neuroscience etc.
1999-present: Numerous evaluation committees (PhDs, Drs. of Medical Sciences, Professorships) at Univ. of Copenhagen, Aarhus Univ., Karolinska, Oslo Univ., Linköping Univ.)
2000-2006:      Board member, Danish Society for Pharmacology and Toxicology
2001-2008:      Scientific Advisory Board member, Novasite Pharmaceuticals, San Diego
2003-:            Executive Committee Member, ‘Basic and Clinical Pharmacology and Toxicology’
2006-:            Editorial Board Member, ‘Molecular Pharmacology’
2006-2012:      Research Strategic Committee (‘Forskningsudvalget’), University of Copenhagen
2006-2010:      Elected as Vice chair and Chair of the Gordon Research Conference on ‘Membrane Transport Proteins in 2008 and 2010, respectively
2008:              Chairman of AERES Evaluation Committee responsible for review of and site-visit at CNRS/INSERM laboratory at Université Pierre et Marie Curie, Paris
2008-2011:      Associate Editor ‘Pharmacology and Therapeutics’
2011-:             Board member and Chairman (2015-2016), Weimann Foundation
2012-2017:       Editorial Board, ‘Journal of Biological Chemistry’
2013-:             Member of Danish Council for Independent Research | Medical Sciences (Det Frie Forskningsråd: Sundhed og Sygdom), Vice Chair from 2015, Chair from 2017.
2015-:             Member of Program Committee for FENS (Federation of European Neuroscience Societies) Forum 2016, July 2016, Copenhagen

Selected Awards and Honors

1993:              Fulbright Senior Scholarship
1998:              Anna Bochardt’s Memorial Award
1998:              Scientific Honorary Medal, Danish Society for Theoretical and Applied Therapy
2002:              Elected Member of the Royal Danish Academy of Sciences and Letters.
2012:              Recipient of ’Kirsten og Freddy Johansens Lægevidenskabelige Forskerpris 2012’.

 

Selected Other Scientific and Academic Activities

1993-:               Invited speaker at ~70 international scientific meetings. Recent examples include:
-       10th Annual SFB35 Symposium on Transmembrane Transporters, Vienna, September 5-8, 2017
-       ISN Brain in Flux Satellite Meeting, Maintenon, France, August 25-28, 2017
-       BioMedical Transporters, Lausanne, Switzerland, August 6-10, 2017
-       Dopamine 2016, Vienna, Austria, September 5-8, 2016
-       Gordon Research Seminar and Conference on Membrane Transport Proteins, Il Ciocco, Italy, June 11-17, 2016 (key note speaker and invited speaker)
-       Neuroscience Day, Aarhus University, May 4, 2016 (key note speaker)
-       American College of Neuropsychopharmacology, Hollywood, Florida, Dec 6-10, 2015
-       ISN Brain in Flux Satellite Meeting, Cairns, Australia, August 20-23, 2015
-       Nordic Neuroscience 2015, Trondheim, Norway, June 10-12, 2015
-       81st Annual Congress of the German Society for Experimental and Clinical Pharmacology and Toxicology, Kiel, Germany, March 10-12, 2015
-       48th Winter Conference on Brain Research, Big Sky, Montana, Jan 24-29, 2015
1992-:             >60 guest lectures at universities and pharmaceutical companies
1999-2016:      Partner in program project funded by the National Institute of Drugs Abuse under the NIH, U.S.A. (collaborators at Columbia, Vanderbilt and Cornell Universities)
2002-:             Ad hoc reviewer of grants for Israeli Science Foundation, National Science Foundation, U.S.A., Austrian Science Foundation, NIH and Human Frontiers Science Program
2004:              Co-organizer of Benzon Symposium No. 51 entitled: ‘Neurotransmitter transporters: Basal function and drug targets’.
2013:              Co-organizer of Benzon Symposium No. 61 entitled: ‘Membrane proteins: structure, function and dynamics’, August 19-22 2013
2015:              Japan Society for the Promotion of Science - Invitation Fellowship (invited 15 days trip with visit to six universities and research institutes)

 

Leadership and Research Administration

1996-:            In charge of Molecular Neuropharmacology and Genetics Lab. counting 25-30 people (3 Associate Prof., 4 post docs, 7 PhD students, 3 RAs, 8 Master’s students and 4 techs). Supported by Danish Research Councils, NIH U.S.A., Lundbeck Foundation, Univ. of Copenhagen and the Novo Nordisk Foundation.
2004-2009:      Director of ‘Center for Pharmacogenomics’ DKK 25 mio from Danish Research Councils
2008-2013:      Principal Investigator, UCPH Program of Excellence (‘Stjerneprogram’) on ‘Biomolecular Scaffolding of Neurotransmitter Receptors and Transporters’ (DKK 25 mio)
2008-2013:      Co-PI (one of four) on UNIK Center of Excellence grant entitled ‘Synthetic Biology’ and awarded DKK 120 mio from 2009-2014 (Director Prof. B. Lindberg Møller).
2010-2015:      Director of ‘Lundbeck Foundation Center for Biomembranes in Nanomedicine’ (together with Dr. Dimitrios Stamou) awarded DKK 34 mio from 2010-2015.
2013-:             Director, UCPH KU2016 Program of Excellence ‘Attention to Dopamine…’, - DKK 19 mio
2016 -:            PI for "Larger biomedical Project", Lundbeck Foundation, DKK 10 mio

 

Teaching and Supervision

1996-:             Since 1996 main supervisor for 24 post docs, 27 PhD student and 33 Master’s students
1998- :           Ad hoc lecturer at PhD courses (KU, Linköping, Karolinska Institutet, Aarhus University)
1996- :           Pregraduate teaching in physiology and pharmacology (medical and human biology students),  including >1000 hours of lectures/class teaching plus preparation/evaluation of written exams, course responsibility and organization of laboratory

 

Research Interests and Expertise

Neurotransmitter transporters and receptors with focus on the dopamine system, molecular pharmacology, addiction (cocaine/amphetamine), psychiatric diseases (schizophrenia, depression, ADHD, autism), Parkinson’s disease, neuronal cell biology, molecular genetics, genetic mouse models

 

Publications

161 publications in peer-reviewed journals (Feb 2018). Several contributions to high impact journals (2 Nature, 1 Nature Neuroscience, 3 Nature Comm., 1 Neuron, 1 Nature Chem Biol, 1 Nature Methods, 4 PNAS, 1 PloS Biology, 3 EMBO J, 1 Current Biology, 1 Elife, 39 J Biol Chem). 16 papers published as conference proceedings/book chapters. Co-inventor on two patents. Google Scholar: ~13,600 citations, H-index = 58 (Feb 2018) (ORCID ID 0000-0002-0020-3807).